August 05, 2022
A recent review, conducted by a team of world-leading polycystic ovary syndrome (PCOS) researchers and caregivers, led by Monash University, provides best practice evidence for more funded research to fill remaining knowledge gaps in this often-neglected condition, and provides a Summary of proponents.
Comprehensive review, now. is published in The lancet, diabetes and endocrinology, highlights the increased need for specialized services and evidence-based resources to optimize best practice diagnosis, care and health outcomes in partnership with women. It also provides an updated point of reference for physicians and other health professionals providing medical care to women with PCOS.
PCOS is a common condition that affects 8-13 percent of women. Diagnosis is often delayed, requiring multiple consultations, and is based on signs of irregular periods, high or excess male hormones including excessive hair growth or severe acne, and ultrasound changes in the ovaries. The condition has metabolic, psychological and reproductive properties and is a major cause of infertility in women.
Professor Helena Teide of the Monash Center for Health Research and Implementation (MCHRI) says the review paves the way for the release of international PCOS guidelines in 2023, generously funded by the National Health and Medical Research Council’s (NHMRC) Center for Research Excellence. get supported. was funded. women’s health in reproductive life,
“Practitioners have significant knowledge gaps in the diagnosis and treatment of PCOS. The review aims to improve accurate diagnosis, limit treatment discrepancies, and remove barriers to the delivery of patient-centered care. It also highlights the need for greater investment in the holistic treatment model and research into this common but complex condition,” said Professor Teide.
Lorna Berry, 52, has PCOS and is a leading consumer in the International PCOS Guidelines.
In her 20s and 30s, Lorna went from doctor to doctor looking for answers and diagnoses for her symptoms. At 32, feeling hopeless and unsupported, she was diagnosed with PCOS.
“Women’s voices with PCOS are very important and it’s time we worked with doctors to get the right diagnosis and treatment,” Lorna said. “PCOS is not just a condition that affects women of childbearing age, it affects women throughout their lives. We cannot allow another generation of women to go unrecognized.”
dr Anju Johm, senior author and director of the only dedicated holistic PCOS service in Australia, based at Monash Health, says: “Women want an accurate and faster diagnosis so they can adapt to lifestyle factors and find effective, personalized treatment. to plan. This requires effective translation tools and resources to educate the community, women and healthcare professionals.”
In 2020, MCHRI researchers released the free, evidence-based AskPCOS app co-developed with women and healthcare professionals. It has 21,000 users in 178 countries and provides essential information, a moderated discussion forum, a symptom tracker, easy-to-use infographics and tools to help make shared decisions with healthcare providers. It is designed solely to inform and improve the health outcomes of women like Lorna and her healthcare providers.
Professor Teide says: “We have researched PCOS extensively and listened to women, many of whom were frustrated by the late diagnosis and disparate treatment of their condition. To improve outcomes for women with PCOS, healthcare professionals should be better informed and engage with women in ways that matter to them, as explained in this important document released today.
Read the paper here: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00163-2/fulltext
As reported on Xperscape, the authors are among the top-ranked PCOS researchers in the world. Professor Helena Teide (1), A/Professor Lisa Moran (4), Prof. Robert Norman (8) and Dr. Anju Johan (10) along with Monash University are the leading educational institutions in the region.
About Monash University
With over 80,000 students, Monash University is Australia’s largest university. In the 60 years since its founding, it has built a reputation for world-leading, high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and presence in Malaysia, China, India, Indonesia and Italy, it is one of Australia’s most internationalized universities.
As a leading international medical research university with the largest medical school in Australia and integrated with Australia’s major teaching hospitals, we are consistently ranked among the top 50 universities in the world for clinical, pre-clinical and health sciences.
For more news, see Medicine, Nursing & Health Sciences or Monash University.
Contact Cheryl Critchley on 0418 312 596 or [email protected]